Chong Pan has been recognized by the National Cancer Institute (NCI) with a Cancer Clinical Investigator Team Leadership Award. Pan, associate professor of medicine and leader of the cancer center’s urothelial carcinoma initiative, was one of 11 award recipients for FY 2011. Formal recognition of the recipients took place recently at the National Institutes of Health in Bethesda, MD.
The leadership awards recognize mid-level clinical researchers at NCI-designated cancer centers throughout the U.S. who participate extensively in collaborative clinical trials. The two-year award included up to $96,440 in salary support.
Pan’s current collaborative translational research efforts include: development of a drug delivery system that allows administration of higher doses of chemotherapy for advanced bladder cancer without increasing toxicity; a micro-dosing trial to determine efficacy of chemotherapy for bladder cancer; targeting alternative signaling pathways to treat prostate cancer; and a drug delivery system to eradicate leukemia stem cells.
Ralph de Vere White, UC Davis Comprehensive Cancer Center director, said Pan was an excellent fit for the NCI recognition.
“The cancer center has stressed the importance of having physician-scientists to bring our laboratory research to our patients, and Chong is a prime example of how successful this program is,” de Vere White said. “We are extremely proud of his accomplishments.”